1. The Peru Cervical Cancer Prevention Study (PERCAPS): the technology to make screening accessible.
- Author
-
Levinson KL, Abuelo C, Salmeron J, Chyung E, Zou J, Belinson SE, Wang G, Ortiz CS, Vallejos CS, and Belinson JL
- Subjects
- Adult, Cryotherapy, Early Detection of Cancer instrumentation, Feasibility Studies, Female, Follow-Up Studies, Human Papillomavirus DNA Tests, Humans, Lost to Follow-Up, Mass Screening instrumentation, Mass Screening organization & administration, Papillomavirus Infections complications, Papillomavirus Infections therapy, Patient Satisfaction statistics & numerical data, Peru, Rural Health Services organization & administration, Specimen Handling instrumentation, Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization, Uterine Cervical Neoplasms virology, Vaginal Smears instrumentation, Early Detection of Cancer methods, Health Services Accessibility organization & administration, Mass Screening methods, Papillomavirus Infections diagnosis, Specimen Handling methods, Uterine Cervical Neoplasms prevention & control, Vaginal Smears methods
- Abstract
Objective: This study utilized a combination of HPV self-sampling, iFTA elute specimen cards, and long distance transport for centralized processing of specimens to determine the feasibility of large-scale screening in remote and transient populations., Methods: This study was performed in two locations in Peru (Manchay and Iquitos). The "Just For Me" cervico-vaginal brush and iFTA elute cards were used for the collection and transport of specimens. Samples were shipped via FedEx to China and tested for 14 types of high-risk HPV using PCR based MALDI-TOF. HPV positive women were treated with cryotherapy after VIA triage, and followed-up with colposcopy, biopsy, ECC, and repeat HPV testing at 6 months., Results: Six hundred and forty three women registered, and 632 returned a sample over a 10 day period. Within 2 weeks, specimens were shipped, samples tested, and results received by study staff. Sixty-eight women (10.8%) tested positive, and these results were delivered over 4 days. Fifty-nine HPV positive women (87%) returned for evaluation and treatment, and 2 had large lesions not suitable for cryotherapy. At 6 months, 42 women (74%) returned for follow-up, and 3 had CIN 2 (all positive samples from the endocervical canal). Ninety eight percent of participants reported that they would participate in this type of program again., Conclusions: Utilizing HPV self-sampling, solid media specimen cards for long distance transport, and centralized high throughput processing, we achieved rapid delivery of results, high satisfaction levels, and low loss to follow-up for cervical cancer screening in remote and transient populations., (Copyright © 2013 Elsevier Inc. All rights reserved.)
- Published
- 2013
- Full Text
- View/download PDF